Products for Research Use Only
RegisterLogin

Spebrutinib besylate

CAT: 0013-GTR19203997-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19203997-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Spebrutinib besylate (CC-292) is a potent, covalent inhibitor of Bruton's tyrosine kinase (Btk) with an IC50 below 0.5 nM. It is widely used in biochemical and cellular research to investigate Btk signaling in autoimmune disorders and B-cell malignancies, with applications in both in vitro and in vivo experimental models.
CAS Number
1360053-81-1
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
O=C (C=C) NC1=CC=CC (=C1) NC2=NC (=NC=C2F) NC3=CC=C (OCCOC) C=C3.O=S (=O) (O) C=1C=CC=CC1
Molecular Formula
C28H28FN5O6S
Molecular Weight
581.62
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Spebrutinib Besylate

Spebrutinib Besylate is the besylate salt form of spebrutinib, an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, spebrutinib targets and covalently binds to BTK, thereby preventing its activity. By irreversibly inhibiting BTK, administration of this agent may lead to an inhibition of B cell receptor (BCR) signaling and may inhibit cell proliferation of B-cell malignancies. BTK, a cytoplasmic tyrosine kinase and member of the Tec family of kinases, plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.

CAS Number1360053-81-1
PubChem CID74892828
IUPAC Namebenzenesulfonic acid;N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide
Molecular FormulaC28H28FN5O6S
Molecular Weight581.6
Topological Polar Surface Area160
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count11
Rotatable Bond Count11
Heavy Atom Count41
Formal Charge0
Complexity745
SMILES
COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F.C1=CC=C(C=C1)S(=O)(=O)O
InChI
InChI=1S/C22H22FN5O3.C6H6O3S/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2;7-10(8,9)6-4-2-1-3-5-6/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28);1-5H,(H,7,8,9)
InChIKey
ABSXPNGWJFAPRT-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Spebrutinib Besylate
CAS: 1360053-81-1
CID: 74892828
Formula: C28H28FN5O6S
MW: 581.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight581.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count11
Rotatable Bond Count11
Exact Mass581.17443297
Monoisotopic Mass581.17443297
Topological Polar Surface Area160 Ų
Heavy Atom Count41
Formal Charge0
Complexity745
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19173695-01Spebrutinib
GTR19205722Molibresib besylate
GTR19176328-01Amlodipine Besylate
GTR19175134-01Cisatracurium besylate
GTR19171884-01Atracurium besylate
GTR19187110-01Mirogabalin besylate
GTR19205784-01Gisadenafil besylate
GTR19163644-01Amlodipine Besylate
GTR19158670-01Atracurium besylate
GTR19223693-01Mesoridazine Besylate

Alternative Products

CatalogName
KEC05381Spebrutinib besylate
HY-18012ASpebrutinib (besylate)
A15008-10Spebrutinib besylate (AVL-292 benzenesulfonate) 10mg
A15008-100Spebrutinib besylate (AVL-292 benzenesulfonate) 100mg
A15008-25Spebrutinib besylate (AVL-292 benzenesulfonate) 25mg
A15008-50Spebrutinib besylate (AVL-292 benzenesulfonate) 50mg
T2603-01Spebrutinib
9413-5AVL-292 (Spebrutinib)
S7173-10mgSpebrutinib (AVL-292)
AR-A04469-01Cisatracurium Besylate EP Impurity B Besylate

Popular Products